tiprankstipranks
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market
ONCO
Oncopeptides AB
RESEARCH TOOLSreports
Want to see SE:ONCO full AI Analyst Report?

Oncopeptides AB (ONCO) Cash flow

9 Followers

Oncopeptides AB Cash Flow

SE:ONCO's free cash flow for Q2 2025 was kr-54.41M. For the 2025 fiscal year, SE:ONCO's free cash flow was decreased by kr37.69M and operating cash flow was kr-54.41M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -222.88Mkr -260.57Mkr -279.49Mkr -420.51Mkr -1.52B
Investing Cash Flow
kr 0.00kr 496.00Kkr -116.00Kkr -2.51Mkr -339.00K
Financing Cash Flow
kr 128.55Mkr 263.81Mkr 106.89Mkr 392.40Mkr 1.03B
End Cash Position
kr 82.25Mkr 178.54Mkr 173.41Mkr 344.51Mkr 362.19M
Free Cash Flow
kr -222.88Mkr -260.57Mkr -279.61Mkr -423.02Mkr -1.52B
Currency in SEK

Oncopeptides AB Cash Flow